AMR Action Fund head aims to boost innovation, funds for new antibiotics
28 January 2022
CIDRAP News spoke with AMR Action Fund CEO Henry Skinner, PhD, about the current state of antibiotic development, the need to fix the broken market for new antibiotics, and how to build a sustainable pipeline. The following excerpts from the conversation have been lightly edited for length and clarity.
Further reading: CIDRAP
Author(s): Chris Dall
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!